Logo Image

Abir O. Kanaan, PharmD

Articles by Abir O. Kanaan, PharmD

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Lawrence D. Garber, MD,Jennifer L. Donovan, PharmD,Abir O. Kanaan, PharmD,Marsha A. Raebel, PharmD,Yanfang Zhao, MA,Jacquelyne C. Fuller, MPH,Shawn J. Gagne, BA,Shira H. Fischer, AB,Jerry H. Gurwitz, MD

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

Latest Updated Articles